omega-n-methylarginine has been researched along with bemesetron in 2 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (bemesetron) | Trials (bemesetron) | Recent Studies (post-2010) (bemesetron) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 254 | 3 | 25 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | bemesetron (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.0093 | |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0093 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.097 | |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.0928 | |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.0093 | |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.0093 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.097 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Hayashi, T; Kagaya, A; Kugaya, A; Motohashi, N; Okamoto, Y; Shinno, H; Takebayashi, M; Uchitomi, Y; Yamaji, T; Yamawaki, S | 1 |
2 other study(ies) available for omega-n-methylarginine and bemesetron
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Cyclic GMP generation mediated by 5-HT-2 receptors via nitric oxide-dependent pathway and its effect on the desensitization of 5-HT-2 receptors in C6 glioma cells.
Topics: Animals; Arginine; Calcium; Chelating Agents; Cyclic GMP; Dopamine Antagonists; Edetic Acid; Egtazic Acid; Glioma; Haloperidol; Ketanserin; Nitric Oxide; omega-N-Methylarginine; Rats; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Tropanes; Tumor Cells, Cultured | 1995 |